azd2563 has been researched along with u 100480 in 4 studies
Studies (azd2563) | Trials (azd2563) | Recent Studies (post-2010) (azd2563) | Studies (u 100480) | Trials (u 100480) | Recent Studies (post-2010) (u 100480) |
---|---|---|---|---|---|
29 | 0 | 9 | 43 | 3 | 34 |
Protein | Taxonomy | azd2563 (IC50) | u 100480 (IC50) |
---|---|---|---|
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baulard, AR; Crauste, C; Déprez, B; Flipo, M; Villemagne, B; Willand, N | 1 |
Biava, M; Cocozza, M; Consalvi, S; Poce, G | 1 |
Balasubramanian, V; Cole, ST; Dhar, N; Marriner, G; Sala, C; Sambandamurthy, VK; Sharma, S; Vocat, A; Zhang, M | 1 |
Betoudji, F; Converse, PJ; Dartois, V; Li, SY; Mdluli, KE; Mendel, CM; Nuermberger, EL; Tasneen, R; Tyagi, S; Williams, K; Yang, T | 1 |
2 review(s) available for azd2563 and u 100480
Article | Year |
---|---|
Tuberculosis: the drug development pipeline at a glance.
Topics: Animals; Antitubercular Agents; Clinical Trials as Topic; Drug Discovery; Humans; Tuberculosis | 2012 |
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development.
Topics: Animals; Antitubercular Agents; Humans; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
2 other study(ies) available for azd2563 and u 100480
Article | Year |
---|---|
In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis.
Topics: Acetamides; Animals; Antitubercular Agents; Cells, Cultured; Colony Count, Microbial; Female; Hypoxia; Latent Tuberculosis; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones | 2014 |
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
Topics: Animals; Antitubercular Agents; Bacterial Load; Diarylquinolines; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Linezolid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Organophosphates; Oxazoles; Oxazolidinones; Pyrazinamide; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |